Serotonin 5-ht6 receptor ligands and butyrylcholinesterase inhibitors displaying antioxidant activity—design, synthesis and biological evaluation of multifunctional agents against alzheimer’s disease

HIGHLIGHTS

• who: Krzysztof Więckowski and colleagues from the Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St, Kraków, Poland have published the article: Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease, in the Journal: (JOURNAL) of 20/08/2022
• what: The authors focused on the development of multifunctional ligands to address both the crucial processes involved in the development of AD and the symptoms resulting from neurodegeneration: antioxidant and metal-chelating activity combined with inhibition . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.